Bosun Asset Management LLC Purchases New Holdings in Phreesia, Inc. (NYSE:PHR)

Bosun Asset Management LLC bought a new position in shares of Phreesia, Inc. (NYSE:PHR - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 10,611 shares of the company's stock, valued at approximately $267,000.

Several other institutional investors and hedge funds have also recently modified their holdings of PHR. Charles Schwab Investment Management Inc. raised its holdings in Phreesia by 10.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company's stock worth $12,415,000 after purchasing an additional 46,209 shares in the last quarter. Wesbanco Bank Inc. boosted its position in shares of Phreesia by 76.9% in the 4th quarter. Wesbanco Bank Inc. now owns 46,000 shares of the company's stock worth $1,157,000 after purchasing an additional 20,000 shares in the last quarter. Barclays PLC increased its position in Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock valued at $2,163,000 after buying an additional 43,225 shares in the last quarter. Franklin Resources Inc. raised its stake in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company's stock valued at $31,495,000 after buying an additional 42,973 shares during the last quarter. Finally, Proficio Capital Partners LLC acquired a new stake in Phreesia in the 4th quarter worth approximately $377,000. 92.10% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on PHR shares. KeyCorp dropped their price objective on shares of Phreesia from $30.00 to $28.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Needham & Company LLC reaffirmed a "buy" rating and set a $29.00 target price on shares of Phreesia in a report on Thursday, March 13th. Piper Sandler reissued an "overweight" rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Canaccord Genuity Group lifted their price objective on shares of Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, March 13th. Finally, DA Davidson reduced their target price on shares of Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia has a consensus rating of "Buy" and an average price target of $31.33.

Insider Transactions at Phreesia

In related news, General Counsel Allison C. Hoffman sold 1,213 shares of the business's stock in a transaction on Wednesday, April 16th. The shares were sold at an average price of $23.81, for a total value of $28,881.53. Following the completion of the sale, the general counsel now directly owns 137,921 shares of the company's stock, valued at $3,283,899.01. The trade was a 0.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Balaji Gandhi sold 1,827 shares of the firm's stock in a transaction dated Wednesday, March 26th. The stock was sold at an average price of $27.46, for a total value of $50,169.42. Following the transaction, the chief financial officer now directly owns 103,591 shares in the company, valued at approximately $2,844,608.86. The trade was a 1.73% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 111,640 shares of company stock worth $3,094,167. 5.80% of the stock is currently owned by insiders.

Phreesia Stock Up 1.6%

NYSE:PHR traded up $0.42 during trading hours on Monday, hitting $26.04. The company's stock had a trading volume of 69,420 shares, compared to its average volume of 434,164. The stock has a fifty day moving average of $25.08 and a 200-day moving average of $24.77. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $1.53 billion, a P/E ratio of -17.75 and a beta of 0.74. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.